HEATHER SCHIEVELBEIN: Open Payments
NPI 1821329962 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,222 in 190 payments from 23 companies in 2025. Trend: 2023 $2,575 · 2024 $2,831 · 2025 $3,222
Food & beverage: $3,222
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 21 | $464 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $373 |
| Corium, LLC | 14 | $317 |
| Lundbeck LLC | 17 | $215 |
| ABBVIE INC. | 20 | $201 |
| Supernus Pharmaceuticals, Inc. | 5 | $197 |
| Teva Pharmaceuticals USA, Inc. | 10 | $188 |
| Vanda Pharmaceuticals Inc. | 9 | $182 |
| Janssen Pharmaceuticals, Inc | 13 | $173 |
| Collegium Pharmaceutical, Inc. | 14 | $156 |
Products named: INGREZZA, CAPLYTA, Azstarys, REXULTI, VRAYLAR, Qelbree, FANAPT, Jornay PM.
Industry payments across TX — which companies pay providers there.
